What the hip replacement study measured
Researchers used TriNetX records for adults who had a first total hip replacement between 2003 and 2023. Exposure meant at least three GLP-1 prescriptions in the year before surgery. Matching on demographics, medical conditions, and available lab results left 1,262 people per group. Prescription records could not confirm who took the medication close to the operation.[1]
Deep vein thrombosis (DVT) within 90 days was recorded in 1.6% of the GLP-1 group and 3.0% of matched controls (relative risk 0.53, 95% confidence interval 0.31 to 0.89). Hospital readmission was 1.1% and 2.8%, respectively (relative risk 0.40, 95% confidence interval 0.22 to 0.71). The study found no statistically significant differences in other 90-day outcomes or in five-year revision and joint-infection outcomes.[1]
Research on surgical wound healing tracks different outcomes. In this hip study, DVT was the only thromboembolic endpoint that differed significantly, and matching may have left differences between patients unaccounted for. The authors called for prospective research before drawing conclusions about clot risk.[1]
What other surgery studies measured
Four randomized trials of perioperative liraglutide in cardiac surgery enrolled 446 patients. The pooled mortality result was based on 1 death among 161 liraglutide patients and 3 among 160 controls (relative risk 0.42, 95% confidence interval 0.06 to 2.81). The wide interval leaves substantial uncertainty. A matched spinal-fusion study of 425 semaglutide users and 2,514 controls found no statistically significant difference in overall complications at 90 days or two years. These were different procedures and outcomes from the hip study.[2][3]
What to discuss before surgery
When planning GLP-1 treatment around surgery, tell the surgical and anesthesia teams which medication you take. Wegovy’s prescribing information describes rare reports of pulmonary aspiration under general anesthesia or deep sedation and says available data are insufficient to determine whether changing fasting instructions or briefly stopping the drug reduces that risk. Follow the instructions from your care team for the planned procedure.[4]